| Myocardial scarring following chemotherapy for multiple myeloma detected using late gadolinium hyperenhancement cardiovascular magnetic resonance. | |
| | |
MedLine Citation:
|
PMID: 19584744 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We present the case of a 60-year-old lady who was treated with chemotherapy for myeloma. Following initiation of bortezomib, she developed heart failure which was associated with a reduction in left ventricular systolic function. A gadolinium enhanced cardiovascular magnetic resonance scan demonstrated midwall hyperenhancement consistent with midwall fibrosis. |
| | |
Authors:
|
Paul W X Foley; Malcolm S Hamilton; Francisco Leyva |
Related Documents
:
|
16288714 - Tnf-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonisch... 19945184 - Myocarditis in children and detection of viruses in myocardial tissue: implications for... 19429974 - Diagnostic exercise: myocarditis due to histophilus somni in feedlot and backgrounded c... 15968604 - Screening for acute myocarditis--is scintigraphy with (99m)tc-anti-granulocyte bw 250/1... 19046784 - Endogenous catecholamine levels and function of the systemic right ventricle following ... 16441724 - Preservation of ventricular capture by anodal stimulation after dislodgment of an epica... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of cardiovascular medicine (Hagerstown, Md.) Volume: 11 ISSN: 1558-2035 ISO Abbreviation: J Cardiovasc Med (Hagerstown) Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-03-30 Completed Date: 2010-06-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101259752 Medline TA: J Cardiovasc Med (Hagerstown) Country: United States |
Other Details:
|
Languages: eng Pagination: 386-8 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Good Hope Hospital, Sutton Coldfield, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
adverse effects* Boronic Acids / adverse effects* Fatal Outcome Female Fibrosis Gadolinium / diagnostic use* Heart Failure / chemically induced*, pathology Humans Magnetic Resonance Imaging Middle Aged Multiple Myeloma / drug therapy Myocardium / pathology Pyrazines / adverse effects* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Boronic Acids; 0/Pyrazines; 0/bortezomib; 7440-54-2/Gadolinium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
Next Document: How long does it take to make an accurate diagnosis in an epilepsy monitoring unit?